A highly multiplexed polymerase chain reaction (PCR)-based assay for detection of common tumor-associated somatic mutations that provides prognostic and predictive markers for available treatments. This detection kit enables simultaneous screening of 45 somatic mutations associated with colorectal cancer tumors in five oncogenes: KRAS, NRAS, BRAF, PIK3CA and AKT.

 

This comprehensive assay offers fast turnaround time of about two hours, ease of use and simplified analysis. EntroGen’s Colorectal Cancer Mutation Detection Panel requires a real-time PCR instrument capable of detecting FAM, ROX, CY5 and VIC fluorescent probes, and is now available for research use.